Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • gswkool gswkool Jun 20, 2014 10:50 AM Flag

    Zacks finally got one right {imo}

    MNTA seems cheap here....acquiring shares....just takes a little patience here....

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Zacks' bottom line was "Hold" (rating 3). This is better than sell (rating 4), but it is not as high as buy (rating 2) or strong buy (rating 1). So, what was it about "hold" that seems right?

      Zacks' text was not consistent with the "hold" rating. I find that articles that are internally inconsistent are lacking in credibility.

      The problem with most agency ratings is that they are based on past stock price movements. We want to look past these for companies that are undergoing radical changes, such as Momenta.

      • 1 Reply to therapeuticshock
      • "So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future" - i believe that's the part they got right. Why didn't they rate it a "buy" at this price? I have no clue. And, yes, that's inconsistent. I suppose they will rate it a buy "after" the stock doubles on good news. Anyhow, I'm not waiting - I'm buying.....GLTA

 
MNTA
21.74+0.47(+2.21%)Jul 6 4:00 PMEDT